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ABSTRACT 
The aim of this work was to investigate the influence of acetone and dimethyl sulfoxide (DMSO) on acety-
lated cashew gun (ACG) nanoparticles parameters and to assess their antimicrobial activity. C1 nanoparticles 
presented smaller size (81.3 nm) than compared to C2 (115.7 nm). Although, acetone formed particles with 
lower PDI value. Both C1 and C2 presented negative zeta potential (-39.8 and -31.7 respectively). Particle 
tracking analysis showed that C1 was slightly more concentrated than C2. No statistical differences (p < 
0.05) between the same samples after 5 months were found. Both samples did not exert inhibitory effect on E. 
coli, on the contrary S. aureus, in which both C1 (36.9%) and C2 (19.9%) provided important inhibitory ef-
fect. C1 presented a more pronounced antifungal effect (81.2%), compared to C2 (18.8%), indicating a prom-
ising platform to be used in several biomedical application.  
Keywords: polysaccharide, nanoparticles, biopolymers, modification, biological applications of polymers. 
1. INTRODUTION  
Nanoscale biopolymer particles have been attracted much interest in research field particularly for design and 
fabrication of new devices for drug delivery systems and applications[1]. Moreover, their singular advanta-
geous features as high surface area and very small size has been gain attention in the field of biomedical ap-
plication as they are able to overpass barriers, which is of high interest in response to the growing threat of 
microbial drug resistance[2]. Nanoparticles biocide effectiveness is suggested to occur due to the ability to 
intimate interact with microbial cell membranes/walls and key proteins/enzymes can both inhibit pathogen 
growth and/or promote cell death, which may represent an alternative to the antibiotics whose resistance has 
been developed [2,3]. 
Nanoparticles can be prepared from a variety of materials, although polymeric nanoparticles obtained from 
natural polymers are playing an important role in drug delivery systems[4,5]. Among natural polymers used 
for this purpose, polysaccharides have superior features as high safety, stability, in addition to be biodegrada-
ble, and biocompatible, have abundant resources in nature and low cost in their processing[6]. 
Moreover, they have the advantage that can be chemically modified aiming to tailoring their physicochemical 
properties towards an improvement of drug concentration in the site of action without suffering 
degradation[5,7].  
Cashew gum (GG) is a polysaccharide extracted from Anacardium occidentale tree, widely present in the 
northeastern part of Brazil [5,8]. It is reported to contain: b- D-galactose (72%), D-glucose (14%), arabinose 
(4.6%), rhamnose (3.2%) and glucuronic acid (4.7%) [8]. This complex heteropolysaccharide, non-toxic and 
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versatile biopolymer has been used as promising material in the field of pharmaceutical, and biomedical ap-
plication[7,9-12]. 
Studies regarding the biological activities of CG demonstrated that it has antimicrobial activity against sever-
al microorganisms including gram-positive bacteria[11] and resistant strains[13]. Its antimicrobial activity 
has been attributed to the presence of anacardic acid[13]. Modifications in CG structure have been exploited 
to improve its technological properties[7,9,10]aiming to allow a more specific drug delivery and increase the 
drug incorporation efficiency into the matrix by increasing its hydrophobicity[5,10,14].  
Acetylation reactions is commonly used to replace polysaccharides hydroxyl sites with acetyl functional 
groups, resulting in several effects on the functional properties of the molecule, giving rise to hydrophobic 
modified polysaccharides[14]. 
Few studies have been reported the use of acetylated CG nanoparticles for drug delivery purposes[7,10] using 
the dialysis method and DMSO as solvent. Although, until now, no antimicrobial activity of modified CG-
based nanoparticles has been reported. 
The aim of this work was to investigate the influence of different solvent, namely acetone and dimethyl sul-
foxide (DMSO), on nanoparticles parameters as well as to study antimicrobial activity of the obtained nano-
particles. The nanoparticles were characterized regarding size, polydispersity index and zeta potential. Parti-
cles tracking analysis (PTA) was conducted to evaluate the concentration of the nanoparticles in suspension, 
and colloidal stability was performed to investigate changes in zeta potential. Antimicrobial activity was per-
formed using gram-negative, gram-positive and fungal strains. 
 
2. MATERIALS AND METHODS 
2.1 MATERIALS 
Cashew gum (CG) were kindly donated by the Laboratory of Polymers of the Federal University of Ceará 
(Fortaleza, Brazil). Crude samples were extracted from native Anacardium accidentale L. tree, isolated and 
purified according methodology previously described by Paula and co-workers[15]. All other reagents were 
of analytical grade (Formamide, pyridine, acetic anhydride, dimethyl sulfoxide were purchase from Vetec 
and pyrene was obtained from Fluka). 
 
2.2 METHODS 
2.2.1 SYNTHESIS OF ACETYLATED CASHEW GUM (ACG) 
CG polysaccharide was chemically modified with acetyl moieties by the methodology proposed by Mozato 
and collaborators as reported in Pitombeira et al. [7] This step is to induce amphiphilic properties in the mate-
rial. Briefly, CG (1 g) was suspended in 20 mL of formamide and dissolved with vigorous stirring at 50°C. 
Pyridine (6 mL) and acetic anhydride (15 mL) were added in the bulk and the mixture was stirred for 24 h. 
Acetylated cashew gum (ACG) was precipitated using 400 mL of water, with further filtration and washing 
with double-deionized water. The recovered material was dried in hot air[7]. 
The modification of CG was characterized by  Infrared Spectroscopy (FT-IR Shimadzu 8300 spectro-
photometer) and magnetic resonance spectroscopy using a Fourier transform Bruker Avance DRX 500 spec-
trometer with an inverse multinuclear gradient probe-head equipped with z-shielded gradient coils and a Sili-
con Graphics workstation (data not shown).  FT-IR analysis were recorded obtaining KBr pellets with the 
samples, in the range of 4,000 to 400 cm
-1
, with a resolution of 2 cm
-1
 and 15 scans. 
1
H NMR (400 MHz, 
DMSO-d6) spectra of 3% w/v were recorded at 353 K. Sodium 2,2-dimethylsilapentane-5- sulphonate (DSS) 
was used as the internal standard [10]. 
 
 
2.2.2 Synthesis ACG nanoparticles 
ACG nanoparticles were prepared according to the method described elsewhere [7,10]. Briefly, ACG (20 
mg) was dissolved in 20 mL of dimethyl sulfoxide (DMSO) and the solution was submitted to agitation with 
magnetic stirring during 30 minutes to ensure complete homogenization, with subsequent dialysis for 24 h 
(molecular weight cut-off14 kD) in double-deionized water (600 mL). Water conductivity was the check 
point to monitor the water changing intervals, which should be similar to double-deionized water (approxi-
mately after 3 days). After dialysis, the nanoparticles were collected from the interior of the membrane, and 
suspended in known volume of ultrapure water, and further freeze-dried when appropriate. 
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2.3 CHARACTERIZATION OF CASHEW GUM NANOPARTICLES 
2.3.1 Particle size, polydispersity index and zeta potential 
 Particle size and zeta potential measurements were carried out on a Malvern Zetasizer Nano, Model ZS 3600, 
analyzer. The hydro-dynamic diameter of the obtained ACG nanoparticles was measured by dynamic light 
scattering (DLS) with laser at a wavelength of 633 nm and a fixed scattering angle of 173◦. Each sample was 
measured three times, under room temperature. 
 
2.3.2 Determination of nanoparticles concentration by particle tracking analysis 
Nanoparticle tracking analysis (NTA) combines laser light scattering microscopy with a charge-coupled de-
vice (CCD) camera, which enables the visualization and recording of nanoparticles in solution. The NTA 
software is then able to identify and track individual nanoparticles moving under Brownian motion and re-
lates the movement to a particle size according to the following formula derived from the Stokes-Einstein 
Equation 1: 
 
           (1) 
 
where Kb is the Boltzmann constant and is the mean-squared speed of a particle at a temperature T, in 
a medium of viscosity η, with a hydrodynamic radius of rh. 
The colloidal stability of the obtained ACG nanoparticles was assessed by storing the suspensions in 
preset temperature and humidity conditions during five months. The stability of the nanoparticles was evalu-
ated comparing the zeta potential of the particles before and after storage. 
 
2.3.3 Colloidal stability studies 
The colloidal stability of the obtained ACG nanoparticles was assessed by storing the suspensions in preset 
temperature and humidity conditions during five months. The stability of the nanoparticles was evaluated 
comparing the zeta potential of the particles before and after storage. 
 
2.4 ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY 
2.4.1 Selected strains and growth conditions 
For the evaluation of antibacterial activity of the nanoparticles, the assays sere performed with S. aureus 
(ATCC 25923) and E. coli (ATCC 25922) strains. For the evaluation of antifungal activity, C. albicans 
(NEWP31). Muller–Hinton broth and MH agar (Difco, USA) were used as growth media. The strains were 
maintained in inclined agar, under temperature of 4°C. Cultures were obtained in Brain Hearth Infusion – 
BHI (Difco Laboratoires) broth before the assays. 
 
2.4.2 Direct contact assay 
For this assay, suspension containing ca. 1.5 x 10
8
 CFU (colony forming unit) mL
-1
 were prepared in saline 
solutions, following the MacFarland scale [16]. Further, 100 L of this suspension was transferred to petri 
dishes containing agar Mueller Hinton. In each dish, 100 L of the nanosuspensions were seeded with a 
Drigalsky’s handle by the spread plate method, and incubated at 37°C, for 24h. Dishes with saline solution 
instead nanoparticles suspensions were used as control. DSMO was used as solvent control. The inhibitory 
effect of each sample was calculated according the following equation: 
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2.5 STATISTICAL ANALYSIS 
All the data were analyzed by the Turkey test ANOVA, considered statistically significant when p value < 
0.05. The results were expressed as mean and ± standard deviation. 
 
3. RESULTS AND DISCUSSION 
 
3.1 Characterization of a CG nanoparticles 
 
3.1.1 Particle size, polydispersity index and zeta potential 
For the development of ACG nanoparticles, the nanoprecipitation by dialysis method was selected. The for-
mation of the nanoparticles is based on the slow exchange of the organic solvent with the non-solvent water 
during dialysis, allowing the precipitation of the polymers into nano-sized scale[17].This method is advanta-
geous due to its low cost, easy application and absence of emulsifiers, in addition to be useful when solvent 
removal is not possible by evaporation [17]. 
Previously, Pitombeira and co-worker developed nanoparticles using ACG for drug delivery purposes using 
DMSO as solvent founding, good parameters regarding particles size, PDI and zeta potential[7]. The nature 
of the solvent chosen to obtain polysaccharide nanoparticles directly influences on the size and PDI. These 
parameters were mainly found to be dependent on interfacial tension and viscosity of the solvent, as already 
studied before[18]. 
Acetone is one of the most preferred solvents to produce nanoparticles by dialysis method as its rapid diffu-
sion from the emulsion droplets from the polymer solution to water promotes an interfacial turbulence which 
contributes for the spontaneous formation of nano-sized particles[19]. Moreover, it is less toxic and easy to 
be removed due to low boiling point, avoiding solvent residual in the final colloidal suspension[17]. In this 
work, DMSO (C1) and acetone (C2) were used to produce ACG nanoparticles. The obtained data are ex-
pressed in Table 1. 
 
Table 1: Characterization of the ACG nanoparticles regarding size, polydispersity index (PDI) and zeta potential by dy-






          Based on the obtained data, it was observed that the particles were statistically different (p< 0.05) re-
garding particle size and PDI, using different solvents. Lower nanoparticles were observed when using 
DMSO as solvent (81.3 nm), compared to those obtained with acetone (115.7) (Table 1). The histograms of 
the obtained nanoparticles are present in Figure 1. 
Both C1 and C2 samples showed narrow distribution, presenting PDI values of 0.219 ± 0.009 and 0.122 
± 0.015 respectively. Although, acetone originated particles with more homogeneous distribution (lower PDI 
value). These results are in accordance with results previously reported ACG to produce nanoparticles by 
dialysis method[7,10].  Same findings were observed by Jeong et al., who studied the influence of different 
solvent, including DMSO and acetone, on the particle size and PDI, in which nanoparticles produced with 
DMSO showed to be smaller than those produced with acetone[20]. This change in particle size could be 
explained by the difference in solvent viscosity, miscibility with water and in the solubility behavior of 
ACG[21]. 
The different sizes of nanoparticles formed are assigned to the different chemical properties of organic sol-
vents. The average sizes of nanoparticles increase or decrease according to the solubility parameters of the 
organic solvents. 
Solvent Sample Particle Size PDI Zeta potential 
DMSO C1 81.3 ± 0.1 0.219 ± 0.009 -39.9 
Acetone C2 115.7 ± 1.3 0.122 ± 0.015 -31.7 





















Figure 1:  Histogram distribution of ACG nanoparticles prepared with DMSO (A) and Acetone (B). 
 
The boiling point of solvent is related to evaporation capacity. Higher boiling point, lower its evapora-
tion rate or volatility. The dipole moment is directly proportional related to the polarity of solvent, that is, 
greater dipole moment and greater polarity. Comparing the values of the described properties (Table 2), 
DMSO presents higher boiling point and dipole moment. It can suggest the greater difficulty of this solvent 
in evaporate of the system together with its greater polarity results in greater difficulty of the gum to interact 
with itself to form NP in relation to acetone. Therefore, it is expected that NPs generated in DMSO are lower 
when compared to those formed in acetone. 
 
Table 2: Physicochemical parameters of DMSO and acetone. 
 
The measurements of zeta potential revealed that both C1 and C2 present negative charge on the surface 
of the nanoparticles, and values higher than 30 mV in modulus, suggesting that the colloidal system is stable 
due to the repulsion of the particles. 
 
3.1.2 Determination of nanoparticles concentration by particles tracking analysis 
Particle tracking analysis (PTA) has been commonly used to measure physical parameters of nanoparticles as 
well as to correlate the number of particles analyzed to concentration. The main advantage of PTA over DLS 
is that this technique can detect small, weakly-scattering particles among large, strong scatterers that would 
dominate the size distribution determined by DLS, avoiding false results[22]. 
           According to the results, the concentrations of nanoparticles founded for C1 and C2 were respectively 
9.24 ± 0.03 x 10
10




 (Figure 2). It could be seen that a slight increase in 
    Hansen parameters 
(Mpa1/2) 
Solvent Boiling Point 
(°C) 
Dipole Moment (D) Dieletric 
Constant (ε) 
δt δd δp δh 
Acetone 56.1 2.69 20.56 20 15.5 10.4 7 
DMSO 189.1 4.06 46.45 26.7 18.4 16.4 10.2 
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the concentration of the nanoparticles were found when the solvent used was DMSO, which corroborate with 
the particle size analysis in which C1 presented lower size compared to C2.  
            In the case of this study, nanoparticles were obtained by promoting the supersaturation of the ACG in 
the selected solvents. It well known that each substance has different degree of saturation depending on their 
properties and the solvent characteristic, including degree of polarity. Moreover, interactions between poly-
mer-solvent-water greatly influences the precipitation process as each solvent enable polymer moieties to 
diffuse at different rates in the ternary system, which affect growth at the solid–liquid interface[22]. 
            According to the obtained results, it was possible to infer that ACG is more soluble in DMSO than in 
acetone, thus the organic solution would be more concentrated, resulting in more concentrated colloidal sus-
pension.  In addition, DMSO-ACG mixture may present a lower diffusivity index compared to acetone-ACG, 
leading to the obtainment of lower particle size since lower diffusion rates slows particle formation[22]. 
 
 
Figure 2: Particle tracking analysis of C1 (A) and C2 (B). 
 
3.1.3 Colloidal stability studies 
The colloidal stability of the ACG nanoparticles obtained with DMSO (C1) and acetone (C2) was evaluated 
regarding zeta potential as this parameter measures the magnitude of the electrostatic interactions, which is 
crucial for the stability of colloidal systems[23]. In addition, possible changes in zeta potential over storage 
could be attributed to solvent residual, thus it was important to evaluate this parameter. Colloidal stability of 
both C1 and C2 ACG nanoparticles was evaluated before and after 5 months, and no statistical differences (p 
< 0.05) between the same samples was found after this period (Figure 3), confirming that both DMSO and 
acetone are suitable to produce stable nanoparticles. 
 
Figure 3: Zeta potential of DMSO (C1) and acetone (C2) ACG nanoparticles before and after 5 months. 
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3.2 Antibacterial and antifungal activity 
The antibacterial and antifungal activity was performed with Gram-negative (E. coli), Gram-positive (S. au-
reus) and fungi (C. albicans) strains aiming to evaluate significant antimicrobial activity among species with 
different characteristic, under contact during 24h. C. albicans was chosen to evaluate antifungal activity as it 
is a human pathogen commonly found, in addition to be recurrent in hospitalized patients. The obtained re-
sults are express in Table 3. 
           The experiments realized with E. coli (EC) with the tested samples did not present significant differ-
ence compared to positive control on the contrary of the experiments realized with S. aureus. These results 
reveal that the chemical composition of bacterial membrane is determinant to induce resistance or suscepti-
bility to entry of substances inside bacteria. The activity against SA may be explained by the facilitated pene-
tration of the nanoparticles over the bacteria cell wall, which is composed by a thick peptidoglycan layer with 
hydrophobic characteristic, on the contrary of EC cell wall, in which the peptidoglycan layer thinner, having 
no affinity with the nanoparticles.  
            Regarding antifungal activity, it was possible to observe that samples obtained with DMSO (C1) pre-
sented a more pronounced antifungal effect (81.2%), compared to nanoparticles produced with acetone (C2) 









), in addition to the smaller size of C1 nanoparticles. The 
cellular membrane of fungi is composed by glycans, soluble and insoluble polysaccharides and chitin, pre-
senting a hydrophobic characteristic, which seems to facilitate the passage of insoluble compounds through 
the membrane, similarly to gram-positive bacteria.  
 




Size (nm) Inhibitory effect 
C. albicans (CA) S. aureus (SA) 
C1 92.4 81.3 81.2 36.9 
C2 18.8 115.7 18.7 19.9 
 
4. CONCLUSIONS 
In this work, ACG based self-assembled nanoparticles were successfully produced by dialysis method, using 
different solvent, namely DMSO and acetone, evidencing that there were significant differences regarding 
particle size and PDI values. On the other hand, unimodal particle size and homogeneous distributions were 
observed using dynamic light scattering for particles produced with both DMSO and acetone. Moreover, both 
C1 and C2 ACG nanoparticles showed good colloidal stability over 5 months confirming that both DMSO 
and acetone are suitable to produce stable nanoparticles. PTA evidenced that the using DMSO as solvent a 
more concentrated suspension was produced, which corroborate with the particle size analysis. Both C1 and 
C2 showed to be stable regarding zeta potential after 5 month of storage, confirming that both DMSO and 
acetone are suitable to produce stable nanoparticles. Regarding antimicrobial activity, none of tested sample 
was effective against E. coli strain, on the contrary of S. aureus, in which both C1 (36.9%) and C2 (19.9%) 
resented significant inhibitory effect. These results suggest that ACG nanoparticles have more affinity to 
gram-negative bacteria, probably due to the presence of a more complex cell wall, with more hydrophobic 
characteristic. Higher inhibitory effects were found against C. albicans, specially with particles produced 
with DMSO (81.2%), probably due to its higher concentration of nanoparticles. Overall, both nanoparticles 
presented suitable physicochemical characteristics, and showed an important antimicrobial effect against 
gram-negative strain (S. aureus) and fungal (C. albincas), indicating a promising platform to be used in sev-
eral biomedical application. 
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